The frequency of rs2231142 in ABCG2 among Asian subgroups: implications for personalized rosuvastatin dosing

The Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for SLCO1B1, ABCG2 , and CYP2C9 and statin‐associated musculoskeletal symptoms

(2022) Rhonda M. Cooper‐DeHoff et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Prevalence of statin intolerance: a meta-analysis

(2022) Ibadete Bytyçi et al.   EUROPEAN HEART JOURNAL

Statin‐associated muscle symptoms—A review: Individualizing the approach to optimize care

(2022) Barbara S. Wiggins et al.   PHARMACOTHERAPY

The Association between ABCG2 421C>A (rs2231142) Polymorphism and Rosuvastatin Pharmacokinetics: A Systematic Review and Meta-Analysis

(2022) Yubin Song et al.   Pharmaceutics

PharmVar GeneFocus : SLCO1B1

(2022) Laura B. Ramsey et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

The Epidemiology and Genetics of Hyperuricemia and Gout across Major Racial Groups: A Literature Review and Population Genetics Secondary Database Analysis

(2021) Faven Butler et al.   Journal of Personalized Medicine

Estradiol regulates intestinal ABCG2 to promote urate excretion via the PI3K/Akt pathway

(2021) Lei Liu et al.   Nutrition & Metabolism

Ensembl 2022

(2021) Fiona Cunningham et al.   NUCLEIC ACIDS RESEARCH

Health Disparities of Cardiometabolic Disorders Among Filipino Americans: Implications for Health Equity and Community-Based Genetic Research

(2021) Gerald Coronado et al.   Journal of Racial and Ethnic Health Disparities

The prevalence of the gout-associated polymorphism rs2231142 G>T in ABCG2 in a pregnant female Filipino cohort

(2020) Youssef Roman et al.   CLINICAL RHEUMATOLOGY

Uricostatic and uricosuric effect of grapefruit juice in potassium oxonate‐induced hyperuricemic mice

(2020) Arshad Mehmood et al.   JOURNAL OF FOOD BIOCHEMISTRY

Sex Differences in Urate Handling

(2020) Victoria L. Halperin Kuhns et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Telmisartan increases systemic exposure to rosuvastatin after single and multiple doses, and in vitro studies show telmisartan inhibits ABCG2-mediated transport of rosuvastatin

(2016) Miao Hu et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Assessment of genetic polymorphisms associated with hyperuricemia or gout in the Hmong

(2016) Youssef M Roman et al.   Personalized Medicine

Impact of ABCG2 and SLCO1B1 polymorphisms on pharmacokinetics of rosuvastatin, atorvastatin and simvastatin acid in Caucasian and Asian subjects: a class effect?

(2015) Bruce K. Birmingham et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Pharmacokinetic Interaction Between Rosuvastatin and Telmisartan in Healthy Korean Male Volunteers: A Randomized, Open-label, Two-period, Crossover, Multiple-dose Study

(2014) Mijeong Son et al.   CLINICAL THERAPEUTICS

Muscle symptoms in statin users, associations with cytochrome P450, and membrane transporter inhibitor use: A subanalysis of the USAGE study

(2013) Matthew K. Ito et al.   Journal of Clinical Lipidology

Effects of polymorphisms in ABCG2, SLCO1B1, SLC10A1 and CYP2C9/19 on plasma concentrations of rosuvastatin and lipid response in Chinese patients

(2013) Hon-Kit Lee et al.   PHARMACOGENOMICS

The effects of green tea polyphenols on drug metabolism

(2012) Chung S Yang et al.   Expert Opinion on Drug Metabolism & Toxicology

Statin-induced myopathy: a review and update

(2011) Thura T Abd et al.   Expert Opinion On Drug Safety

ABCG2 Polymorphism Is Associated With the Low-Density Lipoprotein Cholesterol Response to Rosuvastatin

(2010) B Tomlinson et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

The ABCG2 transporter and its relations with the pharmacokinetics, drug interaction and lipid-lowering effects of statins

(2010) Miao Hu et al.   Expert Opinion on Drug Metabolism & Toxicology

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

(2010)   LANCET

Transporter Pharmacogenetics and Statin Toxicity

(2009) M Niemi   CLINICAL PHARMACOLOGY & THERAPEUTICS

ABCG2 Polymorphism Markedly Affects the Pharmacokinetics of Atorvastatin and Rosuvastatin

(2009) J E Keskitalo et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Population pharmacokinetics of rosuvastatin: implications of renal impairment, race, and dyslipidaemia

(2008) Tsang-Bin Tzeng et al.   CURRENT MEDICAL RESEARCH AND OPINION